5RA0
| |
5R8J
| |
5R8Z
| |
5R8L
| |
5R93
| |
5R9K
| |
5RA2
| |
5R8D
| |
5R8V
| |
5R9A
| |
5R9Q
| |
5RA5
| |
5R8I
| |
5R91
| |
5R9M
| |
5RA1
| |
5R9E
| |
5R8F
| |
5R9U
| |
5R8W
| |
5RA8
| |
5R9C
| |
5R9R
| |
5RA7
| |
5R8A
| PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z1492796719 in complex with INTERLEUKIN-1 BETA | 分子名称: | Interleukin-1 beta, SULFATE ION, ~{N}-[(3~{R})-1,2,3,4-tetrahydroquinolin-3-yl]ethanamide | 著者 | De Nicola, G.F, Nichols, C.E. | 登録日 | 2020-03-03 | 公開日 | 2020-04-22 | 最終更新日 | 2024-03-06 | 実験手法 | X-RAY DIFFRACTION (1.47 Å) | 主引用文献 | Mining the PDB for Tractable Cases Where X-ray Crystallography Combined with Fragment Screens Can Be Used to Systematically Design Protein-Protein Inhibitors: Two Test Cases Illustrated by IL1 beta-IL1R and p38 alpha-TAB1 Complexes. J.Med.Chem., 63, 2020
|
|